Intrathecal Baclofen in Hereditary Spastic Paraparesis

Intrathecal Baclofen in Hereditary Spastic Paraparesis

Introduction: Treatment with intrathecal baclofen (ITB) is a therapeutic option in the management of severe spasticity in patients with hereditary spastic paraparesis (HSP). However, information on the impact of ITB on the natural course of disease, especially the effect of ITB on functional paramet...

Full description

Bibliographic Details
Main Authors: Elke Pucks-Faes, Judith Dobesberger, Gabriel Hitzenberger, Heinrich Matzak, Andreas Mayr, Elena Fava, Eleonora Genelin, Leopold Saltuari
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Neurology
Subjects:
intrathecal baclofen
sporadic spastic paraparesis
hereditary spastic paraparesis
spasticity
device implantation
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2019.00901/full

Internet

https://www.frontiersin.org/article/10.3389/fneur.2019.00901/full

Similar Items